Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recommended Journals
Relevant Topics
- Advances in Stage for Lung Cancer Treatment
- Asbestos
- Asthmatic
- Breathing Disorders
- Breathlessness
- Bronchogenic Carcinoma
- Bronchoscopic Techique
- Bronchoscopy
- COPD
- COPD Treatment
- Chronic Obstructive Pulmonary Disease
- Dyspnea
- Haemoptysis
- Lung
- Lung Adino Carcinoma
- Lung Cancer
- Lung Cancer Facts
- Lung Cancer Prognosis
- Lung Cancer Stages
- Lung Cancer Survival Rate
- Lung Cancer Symptoms in Women
- Lung Cancer Treatment
- Lung Development
- Lung Diseases
- Lung Fibrosis
- Lung Infection and Treatment
- Lung Inflammation and Treatment
- Lung Nodule
- Lung Pain Treatment
- Lung Parenchyma
- Lung Radiation Therapy
- Mesothelioma
- Pulmonary Alveolar Proteinosis
- Pulmonary Angiography
- Pulmonary Arterial Hypertension
- Pulmonary Aspergillosis
- Pulmonary Cancer
- Pulmonary Circulation
- Pulmonary Critical Care
- Pulmonary Dysplasia
- Pulmonary Edema
- Pulmonary Effusion
- Pulmonary Eosinophilia
- Pulmonary Fibrosis
- Pulmonary Function Tests
- Pulmonary Hypoplasia
- Pulmonary Interstitial Fibrosis
- Pulmonary Lymphoma
- Pulmonary Neoplasm
- Pulmonary Parenchyma
- Pulmonary Thromboembolism
- Pulmonolgy
- Respiratory Tract Infection
- Sarcoidosis
- Signs of Lung Cancer
- Small Cell Lung Cancer
- Stage 4 Lung Cancer
- Symptoms of Lung Cancer
- Types of Lung Cancer
Pulmonary Fibrosis
-
Pulmonary fibrosis is a condition that causes lung scarring and stiffness. It develops when the alveoli, tiny air sacs that transfer oxygen to the blood, become damaged and inflamed. Body tries to heal the damage with scars, but these scars collapse the alveoli and make the lungs less elastic. Changes in the lungs can also increase the blood pressure in the pulmonary artery.
-
In Finland, the analysis on pulmonary fibrosis got the result as three different methodologies of epidemiological studies were most commonly used, namely: (1) national registry databases, (2) questionnaire-based studies, and (3) analysis of the health care system's own registry databases. The overall prevalence and incidence of IPF varied in these studies between 0.5-27.9/100,000 and 0.22-8.8/100,000, respectively. According to four studies the mortality and incidence of IPF are rising.
Expert PPTs
- Yuanlin Song
ARDS, lung infectious disease
PPT Version - Denis Hadjiliadis
Susceptibility of CF patients to Pseudomonas acquisition
PPT Version - Maroun Miled Abou-Jaoude
Pulmonary Transplantation
PPT Version | PDF Version
Speaker PPTs
- Shoude Jin
PDF Version - Alsayed Alnahal
Urinary netrin-1 predict early ischemic acute kidney injury after cardiopulmonary bypass
PPT Version | PDF Version - Ping Yang
PDF Version - Gunilla Lindqvist
PDF Version - Roger Mark Engel
PDF Version - Rupal Patel Mansukhani
Correlation of Medication Therapy in Chronic Obstructive Pulmonary Disease(COPD) Patients with 30-day Readmission Rates
PPT Version | PDF Version - Hadeel Faisal Gad
In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
PPT Version | PDF Version - Xin Wang
IL17 Pathway Involves Moderating Pulmonary Hypertension, a common complication of COPD, in Statins Therapy in Smoking Rats
PPT Version | PDF Version